Inhibition of melanogenesis in response to oxidative stress: transient downregulation of melanocyte differentiation markers and possible involvement of microphthalmia transcription factor

J Cell Sci. 2001 Jun;114(Pt 12):2335-44. doi: 10.1242/jcs.114.12.2335.

Abstract

H(2)O(2) and other reactive oxygen species are key regulators of many intracellular pathways. Within mammalian skin, H(2)O(2) is formed as a byproduct of melanin synthesis, and following u.v. irradiation. We therefore analyzed its effects on melanin synthesis. The activity of the rate-limiting melanogenic enzyme, tyrosinase, decreased in H(2)O(2)-treated mouse and human melanoma cells. This inhibition was concentration- and time-dependent in the B16 melanoma model. Maximal inhibition (50-75%) occurred 8-16 hours after a 20 minute exposure to 0.5 mM H(2)O(2). B16 cells withstand this treatment adequately, as shown by a small effect on glutathione levels and a rapid recovery of basal lipid peroxidation levels. Enzyme activities also recovered, beginning to increase 16-20 hours after the treatment. Inhibition of enzyme activities reflected decreased protein levels. mRNAs for tyrosinase, tyrosinase-related protein 1, dopachrome tautomerase, silver protein and melanocortin 1 receptor also decreased after H(2)O(2) treatment, and recovered at different rates. Downregulation of melanocyte differentiation markers mRNAs was preceded by a decrease in microphthalmia transcription factor (Mitf) gene expression, which was quantitatively similar to the decrease achieved using 12-O-tetradecanoylphorbol-13-acetate. Recovery of basal Mitf mRNA levels was also observed clearly before that of tyrosinase. Therefore, oxidative stress may lead to hypopigmentation by mechanisms that include a microphthalmia-dependent downregulation of the melanogenic enzymes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomarkers / analysis
  • Cell Differentiation* / drug effects
  • DNA-Binding Proteins / genetics*
  • DNA-Binding Proteins / metabolism
  • Dose-Response Relationship, Drug
  • Down-Regulation* / drug effects
  • Gene Expression Regulation, Neoplastic / drug effects
  • Glutathione / metabolism
  • Humans
  • Hydrogen Peroxide / pharmacology
  • Kinetics
  • Lipid Peroxidation / drug effects
  • Melanins / metabolism
  • Melanocytes / cytology*
  • Melanocytes / drug effects
  • Melanocytes / enzymology
  • Melanocytes / metabolism*
  • Melanoma / enzymology
  • Melanoma / metabolism
  • Melanoma / pathology
  • Membrane Glycoproteins*
  • Mice
  • Microphthalmia-Associated Transcription Factor
  • Monophenol Monooxygenase / genetics
  • Oxidative Stress* / drug effects
  • Oxidoreductases*
  • Proteins / genetics
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Transcription Factors*
  • Tumor Cells, Cultured
  • Tyrosine 3-Monooxygenase / metabolism

Substances

  • Biomarkers
  • DNA-Binding Proteins
  • MITF protein, human
  • Melanins
  • Membrane Glycoproteins
  • Microphthalmia-Associated Transcription Factor
  • Mitf protein, mouse
  • Proteins
  • RNA, Messenger
  • Transcription Factors
  • Hydrogen Peroxide
  • Oxidoreductases
  • Tyrosine 3-Monooxygenase
  • TYRP1 protein, human
  • Tyrp1 protein, mouse
  • tyrosinase-related protein-1
  • Monophenol Monooxygenase
  • Glutathione